Clinical Trials Directory

Trials / Completed

CompletedNCT00927121

Clinical Investigation on the Acoustic Stimulation in the Treatment of Chronic Tinnitus

l Prospective Clinical Investigation on the Acoustic Stimulation With the "Coordinated Reset of Neural Subpopulations" in the Treatment of Chronic Tinnitus

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
63 (actual)
Sponsor
ANM Adaptive Neuromodulation GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There are many treatments for chronic tinnitus that have been claimed, with varying degrees of statistical reliability. None of those treatments can eradicate the tinnitus completely. Some therapies can reduce the tinnitus symptoms (loudness, annoyance) up to 30%. Thus there is still a need of new treatments that can reduce considerably the tinnitus symptoms and improve the QOL of subjects. Trial objectives: * The aim of this trial is the improvement of the QOL (quality of live) by reducing the Tinnitus- Symptoms of the patient. * To confirm the efficacy and safety of the coordinated reset technology. These objectives will be assessed: * By subjective and objective measurements of the Tinnitus symptoms, loudness and annoyance.

Conditions

Interventions

TypeNameDescription
DEVICEAcoustic CR-Stimulator ANM//Technology: Acoustic coordinated resetThe CR-stimulation was originally developed by Prof. Dr. Dr. Peter Tass for deep brain stimulation (DBS). The CR-stimulation through high frequency short pulses causes a neuronal reorganization in the stimulated brain area establishing a normal neuronal activity. Based on intensive modeling studies, experimental proof of concept (POC) animal studies and a clinical POC, we proved that the pathologic activity can be recuperated to a desynchronized/healthy state with the acoustic CR-stimulation. The acoustic CR-stimulation signal will be generated by the ANM CR-Stimulator and transmitted to the ears through a speaker system

Timeline

First posted
2009-06-24
Last updated
2012-04-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00927121. Inclusion in this directory is not an endorsement.